FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.
复制标题
DOI：
10.1007/s00259-014-2961-x
复制
发表时间：
2015-02
影响因子：
9.1
通讯作者：
Krause, Bernd J.
中科院分区：
文献类型：
--
作者：
Boellaard, Ronald;Delgado-Bolton, Roberto;Oyen, Wim J. G.;Giammarile, Francesco;Tatsch, Klaus;Eschner, Wolfgang;Verzijlbergen, Fred J.;Barrington, Sally F.;Pike, Lucy C.;Weber, Wolfgang A.;Stroobants, Sigrid;Delbeke, Dominique;Donohoe, Kevin J.;Holbrook, Scott;Graham, Michael M.;Testanera, Giorgio;Hoekstra, Otto S.;Zijlstra, Josee;Visser, Eric;Hoekstra, Corneline J.;Pruim, Jan;Willemsen, Antoon;Arends, Bertjan;Kotzerke, Joerg;Bockisch, Andreas;Beyer, Thomas;Chiti, Arturo;Krause, Bernd J.
这些指南的目的是帮助医生推荐、执行、解释和报告成年患者肿瘤成像的FDG PET/CT结果。PET是一种定量成像技术，因此需要通用的质量控制（QC）/质量保证（QA）程序来保持定量的准确度和精密度。重复性和再现性是任何定量测量和/或成像生物标志物的两个基本要求。重复性是指同一患者在同一系统上接受多次检查时获得相同结果的不确定性。然而，成像生物标志物还应具有足够的再现性，即当在不同系统和不同成像部位检查同一患者时，在该患者中产生相同结果的能力。充分的重复性和再现性对于患者的临床管理和多中心试验中FDG PET/CT的使用至关重要。一个共同的标准化成像程序将有助于促进FDG PET/CT成像的适当使用，并增加出版物的价值，因此，它们对循证医学的贡献。此外，获取数据的平台和研究所之间数值的一致性将有可能增强半定量和定量图像解释的作用。精确度和准确性也非常重要，因为FDG PET/CT用于评估肿瘤反应以及诊断、预后和分期。因此，以前的和这些新的指南都专门旨在实现多中心环境中的标准化摄取值协调。
The purpose of these guidelines is to assist physicians in recommending, performing, interpreting and reporting the results of FDG PET/CT for oncological imaging of adult patients. PET is a quantitative imaging technique and therefore requires a common quality control (QC)/quality assurance (QA) procedure to maintain the accuracy and precision of quantitation. Repeatability and reproducibility are two essential requirements for any quantitative measurement and/or imaging biomarker. Repeatability relates to the uncertainty in obtaining the same result in the same patient when he or she is examined more than once on the same system. However, imaging biomarkers should also have adequate reproducibility, i.e. the ability to yield the same result in the same patient when that patient is examined on different systems and at different imaging sites. Adequate repeatability and reproducibility are essential for the clinical management of patients and the use of FDG PET/CT within multicentre trials. A common standardised imaging procedure will help promote the appropriate use of FDG PET/CT imaging and increase the value of publications and, therefore, their contribution to evidence-based medicine. Moreover, consistency in numerical values between platforms and institutes that acquire the data will potentially enhance the role of semiquantitative and quantitative image interpretation. Precision and accuracy are additionally important as FDG PET/CT is used to evaluate tumour response as well as for diagnosis, prognosis and staging. Therefore both the previous and these new guidelines specifically aim to achieve standardised uptake value harmonisation in multicentre settings.
登录
查看更多内容
影响因子：
5.9
作者：
Coulden, Richard;Chung, Peter;Abele, Jon
通讯作者：
Abele, Jon
DOI：
10.1016/j.ijrobp.2006.03.015
发表时间：
2006-08-01
影响因子：
7
作者：
Andrade, Regiane S.;Heron, Dwight E.;Avril, Norbert
通讯作者：
Avril, Norbert
影响因子：
9.3
作者：
Boellaard, Ronald
通讯作者：
Boellaard, Ronald
影响因子：
9.3
作者：
Coleman, R. Edward;Hillner, Bruce E.;Siegel, Barry A.
通讯作者：
Siegel, Barry A.
影响因子：
8.4
作者：
Borst, GR;Belderbos, JSA;Lebesque, JV
通讯作者：
Lebesque, JV